abstract |
This patent application is directed to at least a compound according to formula I ′ shown below or a pharmaceutically acceptable salt thereof wherein ring D, ring A, ring E, ring F, J B , n, J D , J, o, R C1 , R C2 , W, J E , r, J F , s, Z 1 , Z 2 and Z 3 are as defined herein). |